This week, we’re reading about progesterone supply issues, states’ settlement with CVS over Medicaid overbilling for insulin, and the causes of and best practices around drug shortages, among other topics.
- The Hill: FDA approves third over-the-counter opioid overdose nasal spray
- Reuters: US progesterone supplies tighten as menopause treatment demand grows
- Becker’s Payer Issues: States begin collecting from CVS’s $36.5M insulin Medicaid settlement
- Endpoints News: CMS seeks to close Medicare negotiation 'loophole'
- Drug Topics: A Practical Guide for Pharmacy Drug Shortages
- Pharmacy Times: Drug Shortages Are Declining, But Persistent Supply Chain Vulnerabilities Continue to Threaten Access
- Lit Covid (academic study): 'I can contribute so much more but you have to untie my hands' - a qualitative study of COVID-19 pandemic impacts on community pharmacist practice: lessons and future directions.
- HR Dive: Express Scripts, PCMA sue to block Tennessee law breaking up PBMs and pharmacies
- Stars and Stripes: Massachusetts senator urges military to audit Express Scripts
- Illinois Business Journal: Gov. Pritzker announces $25M to strengthen pharmacy access across Illinois
NCPA
